Evidence map›Paper›PMID 19482714›Full record

ReviewFrontiers in bioscience (Scholar edition)2009

Calpain and the glutamatergic synapse.

Shachee Doshi, David R Lynch

Open access · bronzeAbstract readReview
In one paragraph

Review in Frontiers in bioscience (Scholar edition), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Calcium-Activated Calpain Specifically Cleaves Glutamate Receptor IIA But Not IIB at theThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
  9. Article
  10. Regulatory role of calpain in neuronal death.Neural regeneration research · 2018
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Conditional disruption of calpain in the CNS alters dendrite morphology, impairs LTP, and promotes neuronal survival following injury.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2013
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Shachee DoshiDivision of Neurology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
David R Lynch
Children's Hospital of Philadelphia · US

Funding

Regulation of NMDA Receptors in Excitotoxicity by Calpain and FYNR01NS045986 · NINDS · CHILDREN'S HOSP OF PHILADELPHIA · PI LYNCH, DAVID ROBINSON · 2003 to 2011
$2.9M
Regulation of NMDA Receptors in Excitotoxicity by Calpain and FYNR56NS045986 · NINDS · CHILDREN'S HOSP OF PHILADELPHIA · PI LYNCH, DAVID ROBINSON · 2007 to 2007
$413k
NINDS NIH HHS NS45986NINDS NIH HHS R01 NS045986NINDS NIH HHS R56 NS045986
6 · The paper itself

Abstract

Calpain is a ubiquitous protease found in different tissue types and in many organisms including mammals. It generally does not destroy its large variety of substrates, but more commonly disrupts their function. In neurons, many of its substrates become dysregulated as a result of cleavage of their regulatory domain by this protease, leading to altered signaling between cells. In glutamatergic synaptic transmission, direct targets of calpain include all of the major glutamate receptors: NMDA receptors, AMPA receptors and mGluR. By cleaving these receptors and associated intracellular proteins, calpain may regulate the physiology at glutamatergic synapses. As a result, calpain-mediated cleavage in neurons might not only be involved in pathological events like excitotoxicity, but may also have neuroprotective effects and roles in physiological synaptic transmission.

Indexed as

AnimalsCalpainHumansReceptors, GlutamateSynapsesCalpainReceptors, Glutamate

Identifiers

PMID19482714
PMCPMC2895305
OpenAlexW1987823613

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.